GlassScriptPhysician profile
Casey Lynn Ross
NPI 1649523861
$2,738.96
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,635 · 2022: $68.65 · 2024: $35.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $35.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $35.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $638.03 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $341.93 | 2021 | |
| Novo Nordisk INC | $211.03 | 2021 | |
| Clarus Therapeutics INC. | $199.34 | 2021 | |
| Arbor Pharmaceuticals, INC. | $151.83 | 2021 | |
| Eisai INC. | $128.50 | 2021 | |
| Amarin Pharma, INC. | $116.32 | 2021 | |
| Optinose US, INC. | $95.29 | 2021 | |
| Genentech USA, INC. | $84.79 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $82.14 | 2021 | |
| Glaxosmithkline, LLC. | $76.80 | 2021-2022 | |
| Esperion Therapeutics, INC. | $64.93 | 2021 | |
| Amneal Pharmaceuticals LLC | $58.27 | 2021 | |
| Amgen INC. | $57.45 | 2021 | |
| Lilly USA, LLC | $55.32 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.10 | 2021 | |
| Currax Pharmaceuticals LLC | $44.43 | 2021-2022 | |
| Virtus Pharmaceuticals LLC | $37.15 | 2021 | |
| Boston Scientific Corporation | $35.78 | 2024 | Watchman Access System |
| Abbott Laboratories | $30.85 | 2021 | |
| Novartis Pharmaceuticals Corporation | $25.98 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.44 | 2021 | |
| Antares Pharma, INC. | $19.47 | 2021 | |
| Aytu Biopharma, INC. | $19.13 | 2021 | |
| Adlon Therapeutics L.P. | $17.73 | 2021 | |
| Jazz Pharmaceuticals INC. | $17.41 | 2021 | |
| Nestle Healthcare Nutrition INC. | $15.88 | 2021 | |
| Pfizer INC. | $15.78 | 2021 | |
| Neos Therapeutics, LP | $15.38 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.